Recursion Pharmaceuticals saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Recursion Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Recursion Pharmaceuticals has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with three publications in Q2 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 75% of filings. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Recursion Pharmaceuticals is filings its patents. Among the top granted patent authorities, Recursion Pharmaceuticals has 100% of its grants in United States(US).
International Business Machines and Regeneron Pharmaceuticals could be the strongest competitors for Recursion Pharmaceuticals
Recursion Pharmaceuticals stands in second position with respect to its patent publications among its competitors.
Patents related to rare diseases lead Recursion Pharmaceuticals's portfolio
Recursion Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Solid tumor related patents lead Recursion Pharmaceuticals portfolio followed by kidney cancer (renal cell cancer), and mos micro (mpu, mcu & dsp)
Recursion Pharmaceuticals has highest number of patents in solid tumor followed by kidney cancer (renal cell cancer), mos micro (mpu, mcu & dsp), digital signal processors(dsp).
For comprehensive analysis of Recursion Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
